Cargando…
First Attempt To Validate Human IgG Antibody Response to Nterm-34kDa Salivary Peptide as Biomarker for Evaluating Exposure to Aedes aegypti Bites
BACKGROUND: Much effort is being devoted for developing new indicators to evaluate the human exposure to Aedes mosquito bites and the risk of arbovirus transmission. Human antibody (Ab) responses to mosquito salivary components could represent a promising tool for evaluating the human-vector contact...
Autores principales: | Elanga Ndille, Emmanuel, Doucoure, Souleymane, Damien, Georgia, Mouchet, François, Drame, Papa Makhtar, Cornelie, Sylvie, Noukpo, Herbert, Yamadjako, Sandra, Djenontin, Armel, Moiroux, Nicolas, Misse, Dorothee, Akogbeto, Martin, Corbel, Vincent, Henry, Marie-Claire, Chandre, Fabrice, Baldet, Thierry, Remoue, Franck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499371/ https://www.ncbi.nlm.nih.gov/pubmed/23166852 http://dx.doi.org/10.1371/journal.pntd.0001905 |
Ejemplares similares
-
Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area
por: Elanga Ndille, Emmanuel, et al.
Publicado: (2016) -
Effectiveness of insecticidal nets on uncomplicated clinical malaria: a case–control study for operational evaluation
por: Damien, Georgia Barikissou, et al.
Publicado: (2016) -
Human Antibody Response to Aedes albopictus Salivary Proteins: A Potential Biomarker to Evaluate the Efficacy of Vector Control in an Area of Chikungunya and Dengue Virus Transmission
por: Doucoure, Souleymane, et al.
Publicado: (2014) -
Salivary Biomarkers in the Control of Mosquito-Borne Diseases
por: Doucoure, Souleymane, et al.
Publicado: (2015) -
Managing insecticide resistance in malaria vectors by combining carbamate-treated plastic wall sheeting and pyrethroid-treated bed nets
por: Djènontin, Armel, et al.
Publicado: (2009)